Sourbh Suren Garg
Lovely Professional University, Abryl Laboratories Private Limited
About
I am a researcher in nanomedicine and advanced drug delivery systems focusing on diabetes and its complications. My work involves the development of Polymer-based formulations to enhance drug bioavailability, targeted drug delivery, and attenuate adverse effects of conventional therapies. I investigate oxidative stress, inflammatory, and metabolic biomarkers using in vitro and in vivo diabetic and oxidative stress models, and apply molecular docking, in silico approaches, and network pharmacology to elucidate mechanisms and identify therapeutic targets.
Employment
-
Abryl Laboratories Private Limited Executive2019 - 2021
-
Lovely Professional University
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (17)
- o‐Coumaric Acid Promotes Angiogenesis and Wound Healing Under Hyperglycemic Stress Through Modulation of Oxidative Stress and Inflammation Save
- AMPK as a central regulator of metabolic memory: mechanisms and therapeutic opportunities Save
- Integrated biophysical, thermodynamic and cellular evaluation of prunetin as an α-glucosidase inhibitor: Insights from ITC, fluorescence quenching and molecular dynamics Save
- Cubosomes: An emerging nanodrug delivery platform for anti-diabetic medications Save
- Screening of natural epigenetic modifiers for managing glycemic memory and diabetic nephropathy Save
- Guar gum-based nanoformulations: Implications for improving drug delivery Save
- Karrikins: Molecular Association with Strigolactones: Role in Plant Growth Regulation and Quorum Sensing Modulation Save
- Exploitation Property of Silver Nanoparticles in Diabetic Wound Healing Save
- Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions Save
- Biological macromolecules-based nanoformulation in improving wound healing and bacterial biofilm-associated infection: A review Save